Hideji Yako

10PUBLICATIONS
7CO-AUTHORS
BiomaterialsNeural engineeringHaematological tumoursEpigenetics (incl. genome methylation and epigenomics)Biofabrication
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 26, 2026
Hesperetin Rescues Amyloid Beta-Induced Defects in Neurite Outgrowth Under In Vitro Mild Cognitive Impairment-like Cellular Conditions.

|May 04, 2026
The RhoG-Binding Domain of ELMO1 Rescues the PTENopathy-like Phenotype in Oligodendroglial FBD-102b Cells.

|Feb 27, 2026
Hesperetin, Acting Through Inhibition of c-Jun Signaling, Mitigates Hypomyelinating Disease-Associated Stop-Loss Claudin-11-Induced Defective Morphogenesis in Oligodendroglial FBD-102b Cells.

Yuki Miyamoto, Takeru Omata, Yuta Muraki

|Nov 13, 2025
The ErbB2-Dock7 Signaling Axis Mediates Excessive Cell Morphogenesis Induced by Autism Spectrum Disorder- and Intellectual Disability-Associated Sema5A p.Arg676Cys.

Mikito Takahashi, Hideji Yako, Ayaka Suzuki

|Oct 29, 2025
Knocking Down FRMD4A, a Factor Associated with the Brain Development Disorder and a Risk Factor for Alzheimer's Disease, Using RNA-Targeting CRISPR/Cas13 Reveals Its Role in Cell Morphogenesis.

Asahi Honjo, Hideji Yako, Yuki Miyamoto

|Feb 26, 2025
Epalrestat Alleviates Reactive Oxygen Species and Endoplasmic Reticulum Stress by Maintaining Glycosylation in IMS32 Schwann Cells Under Exposure to Galactosemic Conditions.

Hideji Yako, Naoko Niimi, Shizuka Takaku

Pageof 2

Frequent Collaborators

6 joint publications

Junji Yamauchi

5 joint publications

Sookja K Chung

5 joint publications

Yuki Miyamoto

3 joint publications

Akinori Nishi